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Toll-like receptors (TLRs) on macrophages 
and DCs respond to pathogen-derived prod-
ucts to induce the production of effector mol-
ecules that regulate innate and adaptive immune 
responses (Medzhitov, 2001; Akira and Takeda, 
2004; Beutler et al., 2004). These include the 
type I IFNs, IFN- and IFN-, and the pro-
inflammatory cytokine IL-12, which are im-
portant for protective responses to infection 
(O’Garra and Robinson, 2004; Stetson and 
Medzhitov, 2006), and IL-10, which suppresses 
cytokine production by macrophages and DCs, 
thereby limiting the immune response to infec-
tious agents (Moore et al., 2001).
The cytoplasmic regions of TLRs share the 
Toll/IL-1R (TIR) domain, leading to associa-
tions between TLRs and the TIR-containing 
adaptors, MyD88, TIRAP (MAL), TIR domain–
containing adaptor inducing IFN- (TRIF; 
TICAM-1), and TRIF-related adaptor mole-
cule (Akira and Takeda, 2004), upon ligand 
binding. TLR4, the receptor for LPS, utilizes all 
four adaptors, whereas TLR9, the receptor for 
CpG-DNA motifs, uses only MyD88. Differen-
tial responses mediated by distinct TLR ligands 
may be explained in part by selective usage of 
TIR adaptor molecules (Boonstra et al., 2006; 
Stetson and Medzhitov, 2006; Colonna, 2007; 
Schmitz et al., 2007; Rajsbaum et al., 2008).
TLR stimulation induces activation of the 
major mitogen-activated protein kinase (MAPK) 
subtypes (extracellular signal-related kinases 
[ERK]-1/2, Jun N-terminal kinases [JNK], and 
p38) and the IB kinase (IKK) complex for acti-
vation of NF-B transcription factors (Akira and 
Takeda, 2004). TNF receptor-associated factor 
(TRAF) 6 is required for MyD88-dependent 
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Stimulation of Toll-like receptors (TLRs) on macrophages and dendritic cells (DCs) by 
pathogen-derived products induces the production of cytokines, which play an important 
role in immune responses. Here, we investigated the role of the TPL-2 signaling pathway in 
TLR induction of interferon- (IFN-) and interleukin-10 (IL-10) in these cell types. It has 
previously been suggested that IFN- and IL-10 are coordinately regulated after TLR 
stimulation. However, in the absence of TPL-2 signaling, lipopolysaccharide (TLR4) and CpG 
(TLR9) stimulation resulted in increased production of IFN- while decreasing IL-10 pro-
duction by both macrophages and myeloid DCs. In contrast, CpG induction of both IFN- 
and IFN- by plasmacytoid DCs was decreased in the absence of TPL-2, although extracel-
lular signal-regulated kinase (ERK) activation was blocked. Extracellular signal-related 
kinase–dependent negative regulation of IFN- in macrophages was IL-10–independent, 
required protein synthesis, and was recapitulated in TPL-2–deficient myeloid DCs by retro-
viral transduction of the ERK-dependent transcription factor c-fos.
© 2009 Kaiser et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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ulated with CpG, as compared with controls, demonstrating 
that TPL-2 signaling has different consequences depending on 
the cell type activated. Negative regulation of IFN- in macro-
phages and myeloid DCs required protein synthesis and could 
be restored in Tpl-2/ or IL-10/ myeloid DCs by retroviral 
expression of the ERK-dependent transcription factor c-fos.
RESULTS AND DISCUSSION
IFN- is up-regulated and IL-10 is down-regulated in  
Tpl-2/ macrophages and myeloid DCs stimulated with LPS
To determine the role of the TPL-2 signaling pathway in TLR 
regulation of IL-10 and IFN- production, BM-derived macro-
phages (BMDMs) and BM-derived DCs (BMDCs/myeloid 
DCs) were generated from Tpl-2/ or control WT mice. 
Induction of IFN- mRNA and IFN- protein in response 
to LPS stimulation were significantly increased in Tpl-2/ 
BMDMs compared with control cells (Fig. 1 a). In contrast, 
IL-10 mRNA and IL-10 protein were significantly decreased 
in the absence of TPL-2. Increased production of IL-12p40 
and p35 mRNA, and in IL-12p70 and p40 protein, was also 
observed in Tpl-2/ BMDMs (Fig. 1 a).
Similarly, BMDCs from Tpl-2/ mice produced elevated 
levels (mRNA and protein) of IFN-, but reduced amounts 
of IL-10 (Fig. 1 b). However, the increase in IFN- produc-
tion in Tpl-2/ relative to WT cells was less in BMDCs than 
in BMDMs. The elevated amounts of IFN- produced by 
Tpl-2/ BMDMs and BMDCs may result in part from de-
creased production of IL-10 because IL-10 inhibits IFN- 
production (Moore et al., 2001). This may explain why IFN- 
production is less affected by TPL-2 deficiency in BMDCs 
compared with BMDMs because the BMDCs produce lower 
concentrations of IL-10. Consistent with the results using 
Tpl-2/ BMDMs, Tpl-2/ BMDCs produced elevated 
levels of IL-12 p40 and p70 protein and IL-12 p35 and p40 
mRNA (Fig. 1 b) compared with control BMDCs.
LPS induction of ERK phosphorylation in macrophages  
and myeloid DCs is TPL-2 dependent
To determine whether impaired LPS-induced ERK activation 
accounted for the altered cytokine production by Tpl-2/ 
BMDMs, activation of ERK was monitored by specific   
immunoblotting. In WT cells, LPS-stimulated rapid ERK 
phosphorylation, which peaked at 15 min (Fig. 1 a). In con-
trast, LPS-induced ERK phosphorylation was not detected   
in Tpl-2/ BMDMs (Fig. 1 a), whereas JNK and p38 phos-
phorylation were unaffected (Fig. 1 a), as reported previously 
(Dumitru et al., 2000). To confirm that the effects of TPL-2 
deficiency on TLR-induced cytokine production resulted from 
abrogation of ERK activation, WT cells were treated with 
the MEK inhibitor U0126 to block ERK activation while 
leaving p38 or JNK activation unaffected (Favata et al., 1998; 
Davies et al., 2000). U0126 increased IFN- and IL-12 pro-
duction and reduced production of IL-10 by LPS-stimulated 
BMDMs (Fig. S1), similar to the effects of TPL-2 deficiency 
in this cell type (Fig. 1 a). Comparable results were obtained 
with a structurally distinct inhibitor of MEK-1/2, PD184352   
activation of MAPKs and NF-B (Gohda et al., 2004). TRIF-
dependent signaling utilizes TRAF3 (Häcker et al., 2006), 
which couples TRIF and MyD88, to activate TBK1 (Häcker 
et al., 2006; Oganesyan et al., 2006), a kinase that regulates 
the activation of IFN regulatory factor (IRF) 3 and IRF7 
(Honda et al., 2006). It has been proposed that the TRAF6-
dependent pathway, via its activation of MAPKs and IKK, 
participates in the induction of proinflammatory cytokines, 
whereas the TRAF3-dependent pathway coordinately regu-
lates the production of type I IFNs and IL-10 (Häcker et al., 
2006). Thus, the ratio of TRAF6 versus TRAF3 recruitment 
to TLRs may dictate the relative production of proinflamma-
tory cytokines, such as IL-12, versus type I IFNs and IL-10. 
However, the observation that LPS induction of IFN- in 
macrophages and DCs is dependent on TRIF, but not MyD88 
(Akira and Takeda, 2004; Boonstra et al., 2006), whereas in-
duction of IL-10 requires both adaptors (Boonstra et al., 2006), 
indicates that IFN- and IL-10 may not always be coordinately 
regulated. Furthermore, the signals regulating the induction of 
type I IFN differ according to the activating TLR and the cell 
type being stimulated (Colonna, 2007; Schmitz et al., 2007). 
Thus, TLR4-mediated induction of IFN- in macrophages and 
myeloid DCs involves activation of IRF3 (for review see Akira 
and Takeda, 2004; Stetson and Medzhitov, 2006; Colonna, 
2007), whereas TLR9 stimulation of IFN- in these cells is 
mediated via IRF1 (Schmitz et al., 2007). However, TLR9 in-
duction of type I IFN in plasmacytoid DCs (pDCs) involves 
activation of IRF7 (for review see Akira and Takeda, 2004; 
Stetson and Medzhitov, 2006; Colonna, 2007).
The signaling pathways coupling TLRs to the activation 
of MAPKs diverge downstream of TRAF6 and involve dis-
tinct MAPKKKs (MAP 3-kinases; Symons et al., 2006). In 
macrophages, LPS activation of ERK, but not JNK or p38 
MAPK, is mediated by the MAP 3-kinase TPL-2 (Dumitru 
et al., 2000), which phosphorylates and activates the ERK-
specific MAPKKs MEK-1/2 (Salmeron et al., 1996). A role 
for ERK activation in the induction of IL-10 and down-reg-
ulation of IL-12 production has previously been reported (Yi 
et al., 2002; Agrawal et al., 2003; Dillon et al., 2004; Banerjee   
et al., 2006). However, it is still unclear whether the inhi-
bition of IL-12 is a direct effect of TLR ligand-induced ERK 
activation or results as a consequence of IL-10 induction by 
this signaling pathway (Yi et al., 2002; Agrawal et al., 2003; 
Dillon et al., 2004).
In this study, we investigated the role of the TPL-2 sig-
naling pathway in the induction of IFN- and IL-10 in mac-
rophages, myeloid DCs, and pDCs. We demonstrate that 
TLR4 and TLR9 activation of ERK was dependent on TPL-2 
in each of these cell types. Furthermore, we show that TLR 
induction of IL-10 was decreased in Tpl-2/ macrophages 
and myeloid DCs compared with WT control cells; pDCs do 
not produce this cytokine upon TLR stimulation. Levels of 
IFN- and IL-12 were substantially increased in Tpl-2/ 
macrophages and myeloid DCs stimulated with LPS or CpG, 
as compared with controls. In contrast, production of IFN- 
and IFN- was significantly reduced in Tpl-2/ pDCs stim-JEM VOL. 206, August 31, 2009  1865
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In our hands, LPS clearly stimulated ERK phosphorylation in 
WT BMDCs (Fig. 1 b), although at a reduced intensity com-
pared with WT BMDMs (Fig.1 a). This may explain the pre-
vious failure to detect ERK phosphorylation in BMDCs after 
LPS stimulation (Häcker et al., 1999). We show that LPS- 
induction of ERK phosphorylation was blocked in BMDCs 
from Tpl-2/ mice (Fig. 1 b), similarly to BMDMs. p38 MAPK 
phosphorylation was marginally reduced in Tpl-2/ BMDCs 
compared with WT cells after LPS stimulation, but JNK phos-
phorylation was unaffected. Thus, altered cytokine production 
in Tpl-2/ BMDCs after TLR stimulation was associated 
predominantly with a block in ERK activation.
Our data that TPL-2 negatively regulates IL-12 in BMDCs 
are consistent with reports from the Pulendran group that 
pharmacological inhibition of ERK activation increases IL-12 
production by human and mouse DCs (Agrawal et al., 2003; 
Dillon et al., 2004). The negative regulatory effect of TPL-2 
on IFN- production that we observe in BMDCs stimu-
lated with LPS contrasts to the requirement of TPL-2 for op-
timal IL-10 induction (Fig. 1 b). Thus, TLR-induction of IL-10 
and IFN- is oppositely regulated by TPL-2 in both macro-
phages and myeloid DCs.
(a gift from P. Cohen, University of Dundee, Scotland, UK; un-
published data). These data support the hypothesis that TPL-2 
promotes IL-10 production while decreasing IL-12 and IFN- 
production via its activation of the ERK MAPK pathway.
We show that activation of ERK by TLR4 in macrophages 
required TPL-2, in agreement with previous findings (Dumitru 
et al., 2000; Banerjee et al., 2006; Papoutsopoulou et al., 2006). 
Our data also suggest that activation of the TPL-2 signaling 
pathway was required for optimal IL-10 production, but nega-
tively regulated IL-12 production. These findings are in accor-
dance with published data using pharmacological inhibitors to 
block ERK activation in macrophages (Feng et al., 1999; Häcker 
et al., 1999; Yi et al., 2002; Banerjee et al., 2006). Moreover, 
our data suggest that TLR4 activation of the TPL-2 pathway 
negatively regulates the production of IFN-, in contrast to its 
positive effects on IL-10 production.
Although the consequences of TPL-2 deficiency on cyto-
kine production after TLR stimulation were very similar in 
BMDMs and BMDCs (Fig. 1), it has been suggested previ-
ously that LPS does not stimulate ERK activation in BMDCs 
(Häcker et al., 1999). Hence, we reinvestigated whether TLR4 
was actually able to induce ERK phosphorylation in BMDCs. 
Figure 1.  TPL-2 activation in BMDMs and BMDCs after LPS stimulation negatively regulates IFN- and IL-12, but is required for optimal 
IL-10 production. BMDMs (a) and BMDCs (b) generated from wild-type (+/+) and Tpl-2/ (/) mice were stimulated with 100 ng/ml LPS. Cytokine 
levels in culture supernatants were determined by ELISA after 24 h stimulation. Total RNA was extracted from cells stimulated for 3 h, and cytokine mRNA 
expression was measured by quantitative PCR (normalized to ubiquitin mRNA). Graphs show mean of individual cell cultures ± SD (protein, n = 4; mRNA, 
n = 3). *, P < 0.05; **, P < 0.01; ***, P < 0.001; Student’s t test. Data are representative of at least three independent experiments with similar results. 
Whole-cell extracts of BMDMs (a, right) and BMDCs (b, right) were generated after indicated stimulation times and analyzed by immunoblotting with the 
antibodies shown. Results are representative of at least four independent experiments.1866 REGULATION OF IFN- BY TPL-2 | Kaiser et al.
sponse to CpG in a TPL-2–dependent fashion. It was also 
important to determine whether TLR9 induction of ERK 
phosphorylation in BMDMs and BMDCs required TPL-2, 
as it has been recently proposed that TLR9 stimulation 
does  not  induce  ERK  phosphorylation  in  this  cell  type 
(Häcker et al., 1999) and that CpG activation of ERK is not 
affected by TPL-2 deficiency in macrophages (Sugimoto 
et al., 2004).
We show here that CpG induced a more gradual increase in 
ERK phosphorylation in WT BMDMs (Fig. 3 a) than LPS did 
(Fig. 1 a), and that this was abrogated in BMDMs from Tpl-2/ 
mice (Fig. 3 a). CpG clearly stimulated ERK phosphorylation in 
WT BMDCs (Fig. 3 b), although at a reduced intensity com-
pared with WT BMDMs, possibly explaining data from Sugimoto 
et al. (2004), who failed to detect any reduction in ERK phos-
phorylation after CpG stimulation of Tpl-2/ macrophages. The 
CpG stimulation results in increased IFN- production  
in Tpl-2/ macrophages and myeloid DCs, but decreased 
IFN- and IFN- in Tpl-2/ pDCs
Because pDCs are a major source of type I IFNs during im-
mune responses (Stetson and Medzhitov, 2006), we deter-
mined the role of the TPL-2 signaling pathway in TLR- 
induction of IFN- and IFN- in this cell type. As pDCs 
express TLR9, but not TLR4 (Boonstra et al., 2003), we 
stimulated pDCs with CpG rather than LPS in comparison   
to macrophages and myeloid DCs. BMDMs and BMDCs 
obtained from Tpl-2/ mice produced elevated levels of 
IFN- protein, IL-12p40 and IL-12p70 upon CpG stimula-
tion, as compared with the same cell types from WT mice 
(Fig. 2, a and b). Ex vivo Tpl-2/ splenic CD11b+ macro-
phages  purified  directly  from  Tpl-2/  mice  also  showed 
highly elevated levels of IFN- and IL-12p40 and p70 as 
compared with equivalent cells from control mice after CpG 
stimulation (Fig. S2). Furthermore, CpG-induced IL-10 pro-
duction was significantly reduced in Tpl-2/ BMDMs (Fig. 2 a) 
and BMDCs (Fig. 2 b), similar to results observed after LPS 
stimulation. IL-10 production by purified splenic macro-
phages was also reduced compared with control WT cells   
after CpG stimulation (Fig. S2).
Opposite effects of TPL-2 deficiency were observed after 
stimulation of pDCs with CpG. Production of both IFN- 
and IFN- in Tpl-2/ BM-pDCs were significantly reduced, 
as compared with pDCs from WT mice (Fig. 2 c). Furthermore, 
again in contrast to Tpl-2/ BMDMs and BMDCs, a small but 
significant decrease in IL-12p40 and IL-12p70 was observed in 
Tpl-2/ pDCs stimulated with CpG, as compared with con-
trols (Fig. 2 c). Similar effects were obtained with directly puri-
fied ex vivo splenic pDCs (unpublished data). Consistent with 
the hypothesis that pDCs are wired differently to macrophages 
and myeloid DCs, pDCs did not produce IL-10 in response to 
CpG stimulation (unpublished data). Conversely, whereas pDCs 
produced high levels of IFN- after stimulation with CpG, 
IFN- was not detectable in supernatants of BMDMs and 
BMDCs stimulated similarly, even in the absence of TPL-2 
(unpublished data).
Our findings reveal cell-intrinsic differences in the re-
quirements for TPL-2 in TLR-induced signaling in pDCs 
versus macrophages and myeloid DCs. Whereas TPL-2 neg-
atively regulated the induction of optimal IFN- and IL-12 
in macrophages and myeloid DCs after TLR-9 stimulation, 
TPL-2 was required for TLR9 induction of both IFN- and 
IFN- by pDCs. Furthermore, these data extend previous 
studies showing that the signaling requirements for induction 
of type I IFNs in pDCs are distinct to macrophages and my-
eloid DCs (Colonna, 2007; Schmitz et al., 2007).
TPL-2 is required for CpG-induced ERK phosphorylation  
in macrophages, myeloid DCs, and pDCs
Because CpG stimulation of Tpl-2/ pDCs resulted in an 
opposite effect on type I IFN induction than that observed 
in macrophages and myeloid DCs, it was important to de-
termine whether ERK was phosphorylated in pDCs in re-
Figure 2.  Upon stimulation with CpG, TPL-2 negatively regulates 
IFN- and IL-12 in macrophages and conventional DCs, but not in 
pDCs. BMDMs, BMDCs, and pDCs generated from WT and Tpl-2/ mice 
were stimulated with CpG (500 nM) for 24 h. Cytokine production in cul-
ture supernatants was determined by ELISA (mean ± SD; n = 3).  
*, P < 0.05; **, P < 0.01; ***, P < 0.001; Student’s t test. Results are repre-
sentative of at least three independent experiments.JEM VOL. 206, August 31, 2009  1867
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Negative regulation of IFN- by TPL-2 in macrophages 
requires protein synthesis
To determine the requirement for protein synthesis in the 
negative regulation of IFN- mRNA induction by TPL-2, 
Tpl-2/ and WT control BMDMs were stimulated with 
CpG in the presence or absence of cycloheximide (CHX). 
Induction of IFN- mRNA was increased when WT BMDMs 
were stimulated in the presence of CHX compared with un-
treated control, indicating that IFN- expression was nega-
tively regulated by a protein synthesis–dependent mechanism 
(Fig. 4 a). The elevated expression of IFN- mRNA ob-
served in the Tpl-2/ BMDMs, however, was not affected 
by CHX, demonstrating that the negative regulation of   
IFN- production by protein synthesis is TPL-2 dependent. 
Similar results were obtained for IL-12p40 expression (Fig. 4 a); 
however, CHX increased IL-12p40 mRNA not only in WT 
BMDMs but also, to a lesser extent, in Tpl-2/ BMDMs, 
suggesting TPL-2–dependent and –independent mechanisms 
for IL-12p40 mRNA regulation. Similar data were obtained 
with BMDMs stimulated with LPS (unpublished data). This 
protein synthesis requirement for negative regulation of   
IFN- mRNA expression could indicate the action of a TPL-2–
dependent  cytokine  or  transcription  factor  that  negatively 
regulates IFN- transcription.
ERK signaling negatively regulates IFN- and IL-12 
production independent of IL-10
Because IL-10 has profound inhibitory effects on cytokine 
production by TLR-stimulated macrophages (Moore et al., 
2001), it was possible that the increased levels of IFN- and 
IL-12 in Tpl-2/ BMDMs resulted from diminished IL-10 
production. However, we show that stimulation of IL-10/ 
BMDMs with LPS (not depicted) or CpG (Fig. 4 b) in the 
presence of U0126 inhibitor resulted in elevated levels of 
IFN- and IL-12, as compared with controls. In addition, in 
the absence of U0126, the production of IFN- and IL-12 
was increased in IL-10/ BMDMs compared with WT cells. 
reduced signal may also explain the previous failure to detect 
CpG stimulation of ERK phosphorylation in BMDCs (Häcker   
et al., 1999). CpG-induced ERK phosphorylation in BMDCs 
was blocked in the absence of TPL-2 (Fig. 3 b). Using a high 
sensitivity substrate for chemiluminescent detection of phospho-
ERK antibody, CpG was also found to induce phosphorylation of 
ERK in pDCs, which was dependent on TPL-2. CpG-induced 
p38 and JNK phosphorylation in pDCs were minimally af-
fected by the absence of TPL-2 (Fig. 3 c).
Our data show that ERK activation after TLR9 ligation 
required TPL-2 in macrophages, myeloid DCs, and pDCs, 
although the effects of TPL-2 deficiency on cytokine in-
duction were distinct in pDCs compared with the other 
two cell types. The very low levels of ERK phosphoryla-
tion induced by CpG stimulation of pDCs compared with 
BMDMs and BMDCs may explain this differential require-
ment for TPL-2 in cytokine induction in these different 
cell types; it has been established in PC12 cells and fibro-
blasts that the amplitude and duration of ERK signaling   
can dictate the biological effect of this signaling pathway   
(Marshall, 1995; Murphy et al., 2002). Alternatively, it is 
possible that ERK signaling is interpreted differently in 
pDCs compared with macrophages and myeloid DCs as a 
consequence of integration of ERK activation with other 
signaling pathways triggered by TLR9. In accordance with 
the latter possibility, pDCs have been shown to use unique 
signaling pathways for the induction of type I IFNs (Honda 
et al., 2006; Stetson and Medzhitov, 2006; Colonna, 2007; 
Schmitz et al., 2007; Cao et al., 2008; Guiducci et al., 
2008). Consistent with cell type–specific differences for 
ERK in regulating IFN- production, a previous study has 
shown that ERK positively regulates IFN- production by 
mouse embryonic fibroblasts in response to myxoma virus 
infection (Wang et al., 2004), similar to CpG induction of 
IFN- and IFN- in pDCs, but opposite to its negative ef-
fects on IFN- production in macrophages and myeloid 
DCs (Fig. 2).
Figure 3.  TPL-2 is essential for TLR-induced ERK signaling in pDCs. Macrophages (a), myeloid DCs (b), and pDCs (c) were generated from WT and 
Tpl-2/ mice and stimulated with 500 nM CpG for times indicated. Whole-cell extracts were analyzed by immunoblotting with the indicated antibodies. 
Luminescence signals in pDCs blots were visualized using a high sensitivity substrate. Results are representative of three independent experiments with 
similar results.1868 REGULATION OF IFN- BY TPL-2 | Kaiser et al.
Thus, ERK negatively regulates the production of IFN- and 
IL-12 independent of IL-10, but TLR-induced production of 
these cytokines is additionally regulated by the autocrine ef-
fects of IL-10, which is itself positively regulated by ERK.
It has been suggested that TLR stimulation coordinately 
induces the TRAF3-dependent production of IFN- and 
IL-10 (Häcker et al., 2006). However, we have shown previ-
ously that IFN- and IL-10 are not always co-regulated and 
that LPS activates signaling pathways that have different ef-
fects on the expression of these two cytokine genes (Boonstra 
et al., 2006). In keeping with this, we show that TPL-2 acti-
vation of ERK is required for TLR4 and TLR9 induction of 
IL-10, but negatively regulates IFN- production via both 
IL-10–dependent and –independent mechanisms.
Abrogation of ERK signaling in Tpl-2/ macrophages 
significantly reduces both c-fos expression and c-Fos DNA 
binding activity
Our results indicate that negative regulation of IFN- ex-
pression by TPL-2–mediated activation of ERK was depen-
dent on protein synthesis. To identify which transcription 
factors might regulate IFN- transcription in an ERK- 
dependent fashion, LPS and CpG-induced gene expression 
in BMDMs stimulated in the presence or absence of the MEK 
inhibitor UO126 was analyzed by Affymetrix gene array. 
Transcription of the IFN- gene is known to be regulated by 
NF-B, AP-1, and IRFs (for review see Colonna, 2007). 
Analysis of the gene array data revealed that expression of 
mRNAs encoding NF-B and IRF family members was not 
affected by U0126 (unpublished data). However, U0126 
substantially reduced LPS and CpG induction of mRNA en-
coding the AP-1 transcription factor c-fos (unpublished data), 
which was shown to regulate IL-10 and IL-12 expression 
(Dillon et al., 2004). Previous studies with MEK inhibitors 
have shown that ERK signaling is required for IL-10 produc-
tion by myeloid cells triggered via TLR (Yi et al., 2002;   
Dillon et al., 2004). This was suggested to be mediated by 
transcriptional induction of IL-10 by c-Fos, whose expres-
sion is positively regulated by ERK signaling. It has also been 
suggested that negative regulation of IL-12p40 by ERK was 
mediated indirectly as a consequence of reduced IL-10 pro-
duction (Yi et al., 2002). Although ERK down-regulation of 
IL-12p40 production has also been proposed to be mediated 
via c-Fos (Dillon et al., 2004), the regulation of IFN- pro-
duction was not addressed. Our data obtained with IL-10/ 
macrophages demonstrate that ERK negatively regulates IL-12 
and IFN- production independent of IL-10 (Fig. 4 b).
We show that c-fos mRNA expression in macrophages is 
positively regulated by TPL-2 because CpG induced reduced 
levels of c-fos mRNA in Tpl-2/ compared with WT con-
trol BMDMs (Fig. 4 c). Similar results were obtained with 
Figure 4.  TPL-2 negatively regulates TLR-induced IFN- mRNA 
expression via a de novo protein synthesis–dependent mechanism 
and independent of IL-10. (a) Before stimulation with 500 nM CpG for 
3 h, BMDMs generated from WT and Tpl-2/ mice were incubated with 
cycloheximide or left untreated. Total RNA was extracted and the indi-
cated cytokine mRNA expression was measured by quantitative PCR (nor-
malized to HPRT mRNA). The graph shows mean ± SD from two individual 
mice assayed in triplicate cell cultures. Results are representative of two 
independent experiments. (b) Before stimulation with 500 nM CpG,  
BMDMs derived from IL10/ mice were incubated for 30 min with  
2.5 µM U0126 or vehicle control (DMSO). After 24 h stimulation, cytokine 
production in culture supernatants was assayed by ELISA (mean ± SD;  
n = 3). *, P < 0.05; **, P < 0.01; ***, P < 0.001; Student’s t test. (c) BMDMs 
generated from WT and Tpl-2/ mice were stimulated with 500 nM CpG 
for the times indicated and total RNA was extracted. c-fos mRNA expres-
sion was measured by quantitative PCR (normalized to HPRT mRNA).  
*, P < 0.05; **, P < 0.01; and ***, P < 0.001; two-way analysis of variance 
(ANOVA) with Bonferroni correction. (d) BMDMs generated from WT and 
Tpl-2/ mice were stimulated with 500 nM CpG for the times indicated, 
and nuclear extracts were prepared. c-fos binding activity was measured 
by ELISA. Graph shows mean ± SD; n = 3. *, P < 0.05; **, P < 0.01;  
***, P < 0.001; two-way ANOVA with Bonferroni correction. Data in b–d 
are representative of at least three independent experiments.
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containing c-fos-IRES-GFP or Mock-IRES-GFP and flow 
cytometry purified on the basis of GFP expression. Expres-
sion of c-fos decreased the levels of IFN- and IL-12 in 
Tpl-2/, IL-10–/–, and WT cells (Fig. 5) induced after CpG 
stimulation. Whereas negative regulation of IL-12 by c-Fos 
had been proposed previously, it remained unclear whether 
this  was  independent  of  effects  on  IL-10  expression 
(Agrawal et al., 2003; Dillon et al., 2004). We show that 
c-Fos regulates IL-12 production in the presence and ab-
sence of IL-10. Furthermore, the negative regulation of 
IFN- by c-Fos suggests a potential mechanism by which 
the TPL-2 signaling pathway negatively regulates IFN- 
production.
The TPL-2 MAPK signaling pathway has attracted con-
siderable  interest  as  a  possible  target  for  antiinflammatory 
drugs (Hall et al., 2007). Because of its critical role in the in-
duction of TNF (Dumitru et al., 2000; Rousseau et al., 2008), 
several large pharmaceutical companies are developing small 
molecule inhibitors of TPL-2 as potential drugs to treat in-
flammatory diseases (Hall et al., 2007). However, our work 
suggests that TPL-2 inhibition may have undesirable proin-
flammatory effects caused by its complex regulation of cyto-
kine production. Thus, although TPL-2 inhibition might 
decrease TNF production, our data suggest that the production 
of the proinflammatory cytokines IL-12 and IFN- would 
be increased in macrophages and myeloid DCs, whereas pro-
duction of the antiinflammatory cytokine IL-10 would be 
decreased. We also show that TPL-2 regulates cytokine pro-
duction in a cell-specific fashion, positively regulating TLR-
induced IL-12 and IFN- production in pDCs. Our data, 
therefore, raise questions about the validity of TPL-2 as an 
antiinflammatory drug target.
MATERIALS AND METHODS
Mice and primary cells. C57BL/6, Tpl-2/ (Dumitru et al., 2000), and 
IL-10/ (Kühn et al., 1993) mice were bred at the National Institute for 
Medical Research under specific pathogen–free conditions. All protocols for 
breeding and experiments with animals were performed and approved by 
the Home Office, UK, Animals (Scientific Procedures) Act 1986 (Project 
License Number: PPL 80/2236). Macrophages, myeloid DCs, and pDCs 
were generated from BM as previously described (Boonstra et al., 2006). 
BMDM (F4/80+) and BMDC (CD11c+) purities were ≥95%, and pDC 
(CD11b CD11c+ B220+ or 120G8+) purities were ≥98% (MoFlo cytome-
ter; Cytomation). Similarly, spleen cell suspensions were depleted of T cells, 
and DCs and macrophages were purified as CD11b+ (≥95%; Fiorentino   
et al., 1991).
Antibodies, cDNA, plasmids, and reagents. The antibodies used for 
immunoblotting  have  been  previously  described  (Papoutsopoulou  et  al., 
2006). mAbs used for cell purification were as follows: anti-F4/80-PE (Invi-
trogen), anti-CD11c-PE (BD), anti-CD11b-APC (eBioscience), and 120G8- 
Alexa Fluor 488 (Boonstra et al., 2006). Cells were stimulated with Salmonella 
Minnesota LPS (Enzo Biochem, Inc.) or phosphorothioate CpG DNA 
(CpG1668: TCCATGACGTTCCTGATGCT; TriLink Biotech). GM-CSF 
was obtained from Schering-Plough, and Flt3 ligand was purchased from 
Shanghai Genomics. The MEK-1 inhibitor U0126 (Favata et al., 1998) was 
obtained from BIOMOL International; DMSO, cycloheximide, and poly-
brene were purchased from Sigma-Aldrich; Liberase Cl and FuGENE-6 were 
obtained from Roche. The cDNA encoding c-fos was donated by A. Behrens 
(Cancer Research Institute, London, UK).
LPS (unpublished data). At the peak time of c-fos mRNA in-
duction, however, no differences in mRNA expression of 
AP-1 transcription factors, Jund1 or ets-1, were observed be-
tween WT and Tpl-2/ BMDMs (Fig. S3). Reduced c-fos 
mRNA in Tpl-2/ BMDMs stimulated with CpG trans-
lated into reduced c-Fos binding activity, since c-Fos binding 
to a specific AP-1 DNA oligonucleotide was found to be sig-
nificantly reduced in the absence of TPL-2 (Fig. 4 d).
Retroviral transduction of c-fos into Tpl-2/  
and IL-10/ myeloid DCs reduces CpG-induced IFN-  
and IL-12 expression
To investigate the potential role of c-Fos in negative regu-
lation of IFN- and IL-12, BMDCs from Tpl-2/, IL-10/, 
and WT mice were transduced with a retroviral construct 
Figure 5.  c-fos reduces TLR up-regulation of IFN- and IL-12 in 
Tpl-2/, Il-10/, and WT BMDCs, independent of IL-10. BMDCs were 
generated from Tpl-2/ (a), IL-10/ (b), and WT (c) mice and transfected 
with control GFP or c-fos-IRES-GFP encoding vectors. GFP+ BMDCs were 
sorted by MoFlo and stimulated with 500 nM CpG for 24 h. Cytokine produc-
tion in culture supernatants was assayed by ELISA (mean ± SD; n = 3). *, P < 
0.05; **, P < 0.01; and ***, P < 0.001; Student’s t test. Results are representa-
tive of five (a and b) or two (c) independent experiments with similar results.1870 REGULATION OF IFN- BY TPL-2 | Kaiser et al.
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